Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › SYNGENE

SYNGENE

Syngene International Limited
Small-capHealthcare ↗

What the six lenses say about SYNGENE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹415.4
2026-07-10
VWAP · 1Y anchor
₹517
-19.7% from VWAP
P/E · TTM
52.8×
TTM EPS ₹7.9
52-week range
8%
position low→high
RSI(14)
37
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How SYNGENE’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.5
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD20›

The actual numbers

Price vs VWAP (1y)-19.7%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-18.8%
Price vs 50-EMA-6.0%
RSI(14)37
RS vs Nifty 500 · 3M-0.6%
RS vs sector · 3M-12.2%
52-week range8%
Volume vs 30d avg0.65×
Volume vs 60d avg0.29×
ATR(14) · volatility15.3
Bollinger width · vol contraction0.106
FundamentalD333›

The actual numbers

Return on equity (ROE)7.9%
Return on capital (ROCE)10.1%
Operating margin12.3%
Net margin8.5%
Revenue growth · YoY+2.6%
EPS growth · YoY-36.4%
Debt / equity0.09×

Full 8-quarter history in the financials table below.

ValuationD738›

The actual numbers

P/E (TTM)52.8×
TTM EPS₹7.9
52-week range8%
CatalystD642›

The actual numbers

Earnings & momentum39
Capital actions17
Governance150

Every filing in the corporate-announcements panel below.

FlowD960›

The actual numbers

Promoter holding52.7%
Delivery · 30d avg51.3%
Up/down-day asymmetry0.4pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D2 + D9 ) ÷ 2 = 5.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
6
Conviction score 6/100 · avg-decile strength 5.5/10
Conviction score6/100›
TechnicalD2›
FundamentalD3›
ValuationD7›
CatalystD6›
FlowD9›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.6pp
-4.7pp
-11.9pp
+3.0pp
-27.0pp
-29.0pp
Nifty 500
Broad-market baseline
+0.2pp
-4.8pp
-12.4pp
-0.6pp
-32.1pp
-32.8pp
Sector
Own-sector index
—
—
-14.2pp
-12.2pp
-44.9pp
-47.3pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

SYNGENE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
415.40+3.80

Relative strength

RS vs baseline · rebased to 100

SYNGENE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
55.54+0.09

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)7908919441,0188749119171,036
↳ change QoQ—+12.8%+5.9%+7.9%-14.1%+4.2%+0.7%+13.0%
EBITDA (₹cr)220261302344206200209303
EBITDA margin27.9%29.3%32.0%33.8%23.6%21.9%22.8%29.3%
PAT (₹cr)76106131183876715148
↳ change QoQ—+40.2%+23.6%+39.6%-52.5%-23.0%-77.6%+886.7%
Net margin9.6%11.9%13.9%18.0%10.0%7.3%1.6%14.3%
EPS (₹)1.892.643.274.552.151.670.373.67
D/E————————
YoY growth · Mar '26Revenue +1.8% YoYPAT -19.1% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 16 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 May '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 4 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    Allotment of Securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    HIGHgovernance
    Change in Auditors
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 29 Apr '26
    MEDIUMcapital
    Dividend
    ›

    A dividend declaration — a cash return to shareholders.

    View original filing on NSE ↗
  • 29 Apr '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 23 Apr '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds SYNGENE

Mutual funds holding SYNGENE (10)

FundWeightAUM ₹crGrade
Nippon India Small Cap Dir Bns0.70%78,407
Nippon India Small Cap Gr0.70%78,407
Nippon India Small Cap Gr Bns0.70%78,407
Nippon India Multi Cap Bns0.53%54,585
Nippon India Multi Cap Dir Bns0.53%54,585
Nippon India Multi Cap Gr0.53%54,585
ICICI Pru Multicap Gr1.22%17,676
DSP Large & Mid Cap Fund Reg Gr0.90%17,370
DSP ELSS Tax Saver Reg Gr1.07%16,156
HSBC Midcap Gr1.50%14,249

ETFs holding SYNGENE (7)

ETFWeightGrade
DSP Nifty Healthcare ETF0.81%
Aditya BSL Nifty Healthcare ETF0.81%
Axis NIFTY Healthcare ETF0.81%
Zerodha Nifty Smallcap 100 ETF0.77%
ICICI Pru Nifty Healthcare ETF0.77%
Mirae Asset Nifty 500 Healthcare ETF0.67%
Motilal Oswal BSE Healthcare ETF0.57%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare